Updated information and interview with Eleanor Kellon, VMD
Pergolide Availability: No FDA Announcement, Supplies Running Low
by: Erin Ryder, News Editor
May 04 2007 Article # 9526
"More than a month since pergolide mesylate, a drug commonly used to treat pituitary pars intermedia dysfunction (PPID), also known as equine Cushing's disease, was withdrawn for human use, the FDA has yet to make an announcement on whether it will allow bulk shipments of the drug to be imported for veterinary use."
(read the complete article)
No comments:
Post a Comment